Business
LENSAR Announces Presentations at American Academy of Ophthalmology Highlighting the Advantages of Streamline IV in Both Cataract and Astigmatism Corrective Surgery
ORLANDO, Fla.--(BUSINESS WIRE)-- LENSAR, Inc. (NASDAQ: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on femtosecond laser
About this update from Lensar, Inc.
[{"type":"text","content":" ORLANDO, Fla.--(BUSINESS WIRE)--\nLENSAR, Inc. (NASDAQ: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on femtosecond laser surgical solutions for the treatment of cataracts, today announced that three posters and a paper have been accepted for virtual presentations at the Annual Meeting of the American Academy of Ophthalmology (AAO) being held November 13-15, 2020.\n\nPaper Presentation\n\nPaper title: Refractive Outcomes of a Light-Adjustable IOL in Cataract Patients With a History of RK\nPresenter: James D Lehmann, MD, Focal Point Vision, San Antonio, TX\nDate: The poster presentation will be available on the AAO meeting portal starting November 11, 2020\n\nPoster Presentations\n\nPresentation title: Outcome of Arcuate Keratotomy Using Iris Registration–Guided Femtosecond Laser for the Management of Astigmatism During Cataract Surgery\nPresenter: Seong-Jun Lee, MD, PHD, Medical Director, Nuri Eye Clinic, Daejeon, Korea\nDate: The poster presentation will be available on the AAO meeting portal starting November 11, 2020\n\nPresentation title: Outcome of Toric IOLs Aligned With Iris Registration-Guided, FsL-Assisted Capsular Marks for the Management of Astigmatism During Cataract Surgery\nPresenter: Seong-Jun Lee, MD, PHD, Medical Director, Nuri Eye Clinic, Daejeon, Korea\nDate: The poster presentation will be available on the AAO meeting portal starting November 11, 2020\n\nPresentation title: Femtosecond Laser-Assisted Capsulotomy With Capsular Marks for Guiding Toric IOL Alignment During Cataract Surgery\nPresenter: Vasilios F Diakonis, MD, PHD, The Eye Institute of West Florida, Largo, FL\nDate: The poster presentation will be available on the AAO meeting portal starting November 11, 2020\n\nAbout LENSAR\n\nLENSAR is a commercial-stage medical device company focused on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining better visual outcomes, efficiency and reproducibility by providing advanced imaging, simplified procedure planning, efficient design and precision.\nView source version on businesswire.com: https://www.businesswire.com/news/home/202...